Abstract
In this study, we have used an approach that allows us to determine in what region of the polypeptide chain of protein it is required to insert a disulphide bond in order to stabilize it. In our previous paper [Melnik et al., JBSD. 2012] it was proposed that to search for a “weak” site in the protein, it is possible to use programs (for example, PONDR-FIT and IsUnstruct) finding intrinsic disorder protein regions. We suggested that in structured globular proteins, such programs predict not protein regions in the polypeptide chain disordered under native conditions, but “weakened”, feebly stabilized ones. Accordingly, an artificial introduction of SS-bridges using mutations in such regions would reliably result in the protein stabilization. We have taken advantage of this approach to stabilize protein Go from Drosophila melanogaster. The designed SS-bridge increased by 4 degrees the melting temperature of one domain of protein Go.
Keywords: Disulphide bridge, Differential scanning microcalorimetry, Go, Protein intrinsic disorder regions, Protein stability, SS-bridge.
Protein & Peptide Letters
Title:Intrinsic Disorder-Based Design of Stabilizing Disulphide Bridge in Gαo Protein
Volume: 23 Issue: 2
Author(s): Galina S. Nagibina, Ulyana F. Tin, Anatoly S. Glukhov, Tatiana N. Melnik and Bogdan S. Melnik
Affiliation:
Keywords: Disulphide bridge, Differential scanning microcalorimetry, Go, Protein intrinsic disorder regions, Protein stability, SS-bridge.
Abstract: In this study, we have used an approach that allows us to determine in what region of the polypeptide chain of protein it is required to insert a disulphide bond in order to stabilize it. In our previous paper [Melnik et al., JBSD. 2012] it was proposed that to search for a “weak” site in the protein, it is possible to use programs (for example, PONDR-FIT and IsUnstruct) finding intrinsic disorder protein regions. We suggested that in structured globular proteins, such programs predict not protein regions in the polypeptide chain disordered under native conditions, but “weakened”, feebly stabilized ones. Accordingly, an artificial introduction of SS-bridges using mutations in such regions would reliably result in the protein stabilization. We have taken advantage of this approach to stabilize protein Go from Drosophila melanogaster. The designed SS-bridge increased by 4 degrees the melting temperature of one domain of protein Go.
Export Options
About this article
Cite this article as:
Nagibina S. Galina, Tin F. Ulyana, Glukhov S. Anatoly, Melnik N. Tatiana and Melnik S. Bogdan, Intrinsic Disorder-Based Design of Stabilizing Disulphide Bridge in Gαo Protein, Protein & Peptide Letters 2016; 23 (2) . https://dx.doi.org/10.2174/092986652302160105130540
DOI https://dx.doi.org/10.2174/092986652302160105130540 |
Print ISSN 0929-8665 |
Publisher Name Bentham Science Publisher |
Online ISSN 1875-5305 |
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
Related Articles
-
Preparation of Disubstituted Phenyl Propargyl Alcohols, their Use in Oxathiolene Oxide Synthesis, and Evaluation of the Oxathiolene Oxide Products as Anticarcinogenic Enzyme Inducers
Letters in Organic Chemistry Green Chemistry Approach as a Versatile Platform for Nanoparticles with Biomedical Applications
Nanoscience & Nanotechnology-Asia Unfolding During Urea Denaturation of a Low Molecular Weight Phytocystatin (Thiol Protease Inhibitor) Purified from Phaseolus mungo (Urd)
Protein & Peptide Letters Nanomaterials as Emerging Environmental Threats
Current Chemical Biology High-Throughput Screening Assays to Discover Small-Molecule Inhibitors of Protein Interactions
Current Drug Discovery Technologies Understanding the Cardiovascular Actions of Soy Isoflavones: Potential Novel Targets for Antihypertensive Drug Development
Cardiovascular & Hematological Disorders-Drug Targets Targeting Tumor Proteasome with Traditional Chinese Medicine
Current Drug Discovery Technologies Recent Applications of Doebner, Doebner-von Miller and Knoevenagel-Doebner Reactions in Organic Syntheses
Current Organic Synthesis Present Scenario of M-Cell Targeting Ligands for Oral Mucosal Immunization
Current Drug Targets To Analyze the Amelioration of Phenobarbital Induced Oxidative Stress by Erucin, as Indicated by Biochemical and Histological Alterations
Anti-Cancer Agents in Medicinal Chemistry A Novel Antiproliferative and Antifungal Lectin from Amaranthus viridis Linn Seeds
Protein & Peptide Letters Biochemical, Biomedical and Metabolic Aspects of Imidazole-Containing Dipeptides with the Inherent Complexity to Neurodegenerative Diseases and Various States of Mental Well-Being: A Challenging Correction and Neurotherapeutic Pharmaceutical Biotechnology for Treating Cognitive Deficits, Depression and Intellectual Disabilities
Current Pharmaceutical Biotechnology Anticancer Activity of Organogallium(III) Complexes in Colon Cancer Cells
Anti-Cancer Agents in Medicinal Chemistry Exosome-like Nanoparticles: A New Type of Nanocarrier
Current Medicinal Chemistry Multilanthanide Systems for Medical Imaging Applications
Recent Patents on Nanomedicine Comparison of Two Types of Amino Acid Solutions on <sup>177</sup>Lu-Dotatate Pharmacokinetics and Pharmacodynamics in Patients with Metastatic Gastroenteropancreatic Neuroendocrine Tumors
Current Radiopharmaceuticals Controlled Release of Insulin in Blood from Strontium-Substituted Carbonate Apatite Complexes
Current Drug Delivery Noscapine-loaded PLA Nanoparticles: Systematic Study of Effect of Formulation and Process Variables on Particle Size, Drug Loading and Entrapment Efficiency
Pharmaceutical Nanotechnology ThermoTRP Channels in Nociceptors: Taking a Lead from Capsaicin Receptor TRPV1
Current Neuropharmacology Oligonucleotide Aptamers for Glioma Targeting: An Update
Central Nervous System Agents in Medicinal Chemistry